Stock Comparison
BNTX vs VRTX
BioNTech SE and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$23.36B
$123.94B
P/E (TTM)
—
28.5
Forward P/E
7.0
25.7
Price/Sales
8.8
9.9
Price/Book
1.1
6.1
EV/EBITDA
32.5
23.2
Dividend Yield
—
—
Profitability
Net Margin
-44.95%
35.40%
Operating Margin
-51.83%
38.97%
Return on Equity
-9.30%
23.50%
Return on Assets
-5.41%
11.90%
Growth (YoY)
Revenue Growth
-59.50%
12.50%
Earnings Growth
-43.20%
8.00%
Price & Risk
Beta
1.3
0.3
52-Week High
$119.34
$529.65
52-Week Low
$83.89
$376.62
Analyst Target
$120.75
$559.28
Compare BNTX and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.